Cargando…

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health

Background: In the last decade there has been a progressive increase in the use of new psychoactive substances (NPSs) that are not yet under international control. In particular, novel synthetic opioids (NSOs) have reappeared on the recreational drug market in the last few years. As a result, the us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovrecic, Barbara, Lovrecic, Mercedes, Gabrovec, Branko, Carli, Marco, Pacini, Matteo, Maremmani, Angelo G. I., Maremmani, Icro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352208/ https://www.ncbi.nlm.nih.gov/pubmed/30634521 http://dx.doi.org/10.3390/ijerph16020177

Ejemplares similares

Trends of Hospitalization for Acute Alcohol Intoxication in Slovenian Children and Adolescents with and without Dual Disorder. Implications for a Correct Intervention
por: Lovrecic, Mercedes, et al.
Publicado: (2020)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later
por: Pani, Pier Paolo, et al.
Publicado: (2020)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2012)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
por: Barbuti, Margherita, et al.
Publicado: (2023)

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
por: Maremmani, Icro, et al.
Publicado: (2010)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
por: Maremmani, Icro, et al.
Publicado: (2023)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Randomized Trial on the Effects of a Mindfulness Intervention on Temperament, Anxiety, and Depression: A Multi-Arm Psychometric Study
por: Poli, Andrea, et al.
Publicado: (2022)

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers
por: Cipollone, Giada, et al.
Publicado: (2020)

Substance Use/Dependence in Psychiatric Emergency Setting Leading to Hospitalization: Predictors of Continuity of Care
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2022)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model
por: Cenci, Davide, et al.
Publicado: (2022)

Optical genome mapping in an atypical Pelizaeus-Merzbacher prenatal challenge
por: Rogac, Mihael, et al.
Publicado: (2023)

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review
por: Caputo, Fabio, et al.
Publicado: (2009)

Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis
por: Butelman, Eduardo R., et al.
Publicado: (2018)

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
por: Maremmani, Icro, et al.
Publicado: (2015)

The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability
por: Carbone, Manuel Glauco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2c01bs0fd60d5jrr4h18214sud